Cargando…
Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study
BACKGROUND: Epidemiologic evidence for a serum cholesterol-prostate cancer link is mixed. Prostate-specific antigen (PSA) is positively correlated with cholesterol, potentially increasing PSA-driven biopsy recommendations in men with high cholesterol, though biopsy compliance may be lower in men wit...
Autores principales: | Jamnagerwalla, Juzar, Howard, Lauren E., Allott, Emma H., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freeman, Michael R., Freedland, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021229/ https://www.ncbi.nlm.nih.gov/pubmed/29282360 http://dx.doi.org/10.1038/s41391-017-0030-9 |
Ejemplares similares
-
Baseline Subject Characteristics Predictive of Compliance with Study-Mandated Prostate Biopsy in Men at Risk of Prostate Cancer: Results from REDUCE
por: Fischer, Sean, et al.
Publicado: (2016) -
Racial differences in prostate inflammation: results from the REDUCE study
por: Vidal, Adriana C., et al.
Publicado: (2016) -
Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer
por: Allott, Emma H., et al.
Publicado: (2018) -
Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study
por: Jenkins, Kimberly R., et al.
Publicado: (2021) -
Aspirin and prostate cancer prevention
por: Vidal, Adriana C., et al.
Publicado: (2015)